Skip to main content
. 2020 Jul 10;196(12):1116–1127. doi: 10.1007/s00066-020-01662-4

Table 2.

γH2AX foci per cell before RT, 30 min after ex vivo exposure to 0.5 Gy or 30 min after the first fraction of RT

RT EWBD (mSV) γH2AX foci per cell
Before RT
0 Gy
Ex vivo
0.5 Gy
Post RT
Orthovoltage 2.52 0.011 n.a. 0.106
2.36 0.167 5.44 0.186
2.79 0.051 4.81 0.072
3.49 0.200 5.23 0.211
2.44 0.310 6.15 0.215
2.55 0.169 5.98 0.816
3.24 0.940 7.32 1.371
3.15 0.200 5.82 0.321
2.34 0.147 5.02 0.272
2.39 0.071 4.88 0.199
Mean ± SD 2.73 ± 0.42 0.227 ± 0.265 5.63 ± 0.80 0.377 ± 0.406
Linac 9.99 0.076 5.46 0.183
13.48 0.183 6.81 0.358
9.97 0.060 6.23 0.745
14.67 0.239 n.a. 0.446
10.96 0.093 5.77 0.074
13.30 0.252 6.02 0.199
9.50 0.109 5.33 0.210
12.63 0.025 5.84 0.010
Mean ± SD 11.81 ± 1.95 0.130 ± 0.085 5.92 ± 0.499 0.278 ± 0.235

All patients

Mean ± SD

5.26 ± 3.90 0.184 ± 0.206 5.76 ± 0.680 0.333 ± 0.335

RT radiation therapy, EWBD equivalent whole-body dose, SD standard deviation, Linac linear accelerator